These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 9354463

  • 1. Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors.
    Fulda S, Friesen C, Los M, Scaffidi C, Mier W, Benedict M, Nuñez G, Krammer PH, Peter ME, Debatin KM.
    Cancer Res; 1997 Nov 01; 57(21):4956-64. PubMed ID: 9354463
    [Abstract] [Full Text] [Related]

  • 2. Betulinic acid: a new chemotherapeutic agent in the treatment of neuroectodermal tumors.
    Fulda S, Jeremias I, Pietsch T, Debatin KM.
    Klin Padiatr; 1999 Nov 01; 211(4):319-22. PubMed ID: 10472570
    [Abstract] [Full Text] [Related]

  • 3. Betulinic acid-induced apoptosis in glioma cells: A sequential requirement for new protein synthesis, formation of reactive oxygen species, and caspase processing.
    Wick W, Grimmel C, Wagenknecht B, Dichgans J, Weller M.
    J Pharmacol Exp Ther; 1999 Jun 01; 289(3):1306-12. PubMed ID: 10336521
    [Abstract] [Full Text] [Related]

  • 4. The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis.
    Raisova M, Hossini AM, Eberle J, Riebeling C, Wieder T, Sturm I, Daniel PT, Orfanos CE, Geilen CC.
    J Invest Dermatol; 2001 Aug 01; 117(2):333-40. PubMed ID: 11511312
    [Abstract] [Full Text] [Related]

  • 5. Betulinic acid induces apoptosis through a direct effect on mitochondria in neuroectodermal tumors.
    Fulda S, Debatin KM.
    Med Pediatr Oncol; 2000 Dec 01; 35(6):616-8. PubMed ID: 11107130
    [Abstract] [Full Text] [Related]

  • 6. Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells.
    Fulda S, Susin SA, Kroemer G, Debatin KM.
    Cancer Res; 1998 Oct 01; 58(19):4453-60. PubMed ID: 9766678
    [Abstract] [Full Text] [Related]

  • 7. Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid.
    Fulda S, Scaffidi C, Susin SA, Krammer PH, Kroemer G, Peter ME, Debatin KM.
    J Biol Chem; 1998 Dec 18; 273(51):33942-8. PubMed ID: 9852046
    [Abstract] [Full Text] [Related]

  • 8. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells.
    Fulda S, Sieverts H, Friesen C, Herr I, Debatin KM.
    Cancer Res; 1997 Sep 01; 57(17):3823-9. PubMed ID: 9288794
    [Abstract] [Full Text] [Related]

  • 9. Correspondence re: S. Fulda et al., Betulinic acid triggers CD95 (Apo1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res., 57: 4956-4964, 1997.
    Rieber M, Rieber MS.
    Cancer Res; 1998 Dec 15; 58(24):5876-7. PubMed ID: 9865749
    [No Abstract] [Full Text] [Related]

  • 10. Activation of the CD95 (APO-1/Fas) pathway in drug- and gamma-irradiation-induced apoptosis of brain tumor cells.
    Fulda S, Scaffidi C, Pietsch T, Krammer PH, Peter ME, Debatin KM.
    Cell Death Differ; 1998 Oct 15; 5(10):884-93. PubMed ID: 10203687
    [Abstract] [Full Text] [Related]

  • 11. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2.
    Dirsch VM, Stuppner H, Vollmar AM.
    Cancer Res; 2001 Aug 01; 61(15):5817-23. PubMed ID: 11479221
    [Abstract] [Full Text] [Related]

  • 12. Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases).
    Los M, Herr I, Friesen C, Fulda S, Schulze-Osthoff K, Debatin KM.
    Blood; 1997 Oct 15; 90(8):3118-29. PubMed ID: 9376593
    [Abstract] [Full Text] [Related]

  • 13. p53-induced apoptosis in the human T-ALL cell line CCRF-CEM.
    Geley S, Hartmann BL, Hattmannstorfer R, Löffler M, Ausserlechner MJ, Bernhard D, Sgonc R, Strasser-Wozak EM, Ebner M, Auer B, Kofler R.
    Oncogene; 1997 Nov 13; 15(20):2429-37. PubMed ID: 9395239
    [Abstract] [Full Text] [Related]

  • 14. Differential regulation of doxorubicin-induced mitochondrial dysfunction and apoptosis by Bcl-2 in mammary adenocarcinoma (MTLn3) cells.
    Huigsloot M, Tijdens IB, Mulder GJ, van de Water B.
    J Biol Chem; 2002 Sep 27; 277(39):35869-79. PubMed ID: 12107157
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
    Ibrado AM, Huang Y, Fang G, Liu L, Bhalla K.
    Cancer Res; 1996 Oct 15; 56(20):4743-8. PubMed ID: 8840993
    [Abstract] [Full Text] [Related]

  • 16. Betulinic Acid-Mediated Apoptosis in Human Prostate Cancer Cells Involves p53 and Nuclear Factor-Kappa B (NF-κB) Pathways.
    Shankar E, Zhang A, Franco D, Gupta S.
    Molecules; 2017 Feb 10; 22(2):. PubMed ID: 28208611
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Betulinic acid promotes TRAIL function on liver cancer progression inhibition through p53/Caspase-3 signaling activation.
    Xu Y, Li J, Li QJ, Feng YL, Pan F.
    Biomed Pharmacother; 2017 Apr 10; 88():349-358. PubMed ID: 28119237
    [Abstract] [Full Text] [Related]

  • 19. Fas-induced activation of the cell death-related protease CPP32 Is inhibited by Bcl-2 and by ICE family protease inhibitors.
    Armstrong RC, Aja T, Xiang J, Gaur S, Krebs JF, Hoang K, Bai X, Korsmeyer SJ, Karanewsky DS, Fritz LC, Tomaselli KJ.
    J Biol Chem; 1996 Jul 12; 271(28):16850-5. PubMed ID: 8663439
    [Abstract] [Full Text] [Related]

  • 20. Betulinic Acid Inhibits Cell Proliferation in Human Oral Squamous Cell Carcinoma via Modulating ROS-Regulated p53 Signaling.
    Shen H, Liu L, Yang Y, Xun W, Wei K, Zeng G.
    Oncol Res; 2017 Aug 07; 25(7):1141-1152. PubMed ID: 28109089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.